Printer Friendly

Articles from Chain Drug Review (November 16, 1992)

1-43 out of 43 article(s)
Title Author Type Words
Attention to quality is key factor to success in private label arena. 717
Bindley results continue strong. 762
Cardinal boosts sales, earnings through acquisitions. 591
Cardinal bottom line soars 70%. 387
Chain drug stocks continue to post records in October. Industry Overview 877
Challenge and reward mark year for FoxMeyer. 955
Chase underscores expertise with launch of softgel technology. 682
Chesebrough-Pond's continues make-over. Sloan, Pat 612
Commons forges unique path in wholesaling arena. 353
Cosmetics companies debuting medicated products. 842
Cost containment, market expansion help Alco thrive. 517
Curls and color spark sales in hair care category. Fuller, Bonnie Industry Overview 741
Diabetes products sales grow. Industry Overview 683
Durr acquisition key for Bergen Brunswig. 516
Eckerd history is microcosm of industry. Editorial 597
Gallup examines shoppers for PLMA. 431
Genovese is offering home delivery service. 560
Improving counseling skills. 616
Kroger earnings slip in quarter. 383
Manufacturers expand facilities. 345
Many consumers fail to realize seriousness of diabetes effects. 338
McKesson income up 14% in qtr. 608
McKesson reexamines strategy. 810
Medicaid cost containment disputed. 405
OBRA clarification. 502
Package design key PL strategy. 507
Personalized service key at Humiston-Keeling. 585
Phar-Mor awarded financing. 631
Phar-Mor's credibility a problem. 686
Retail perspectives: marketers must redirect efforts to aging baby boomers. 947
Rite Aid, GTE Spacenet on verge of pact. 517
Schein is keeping up with demand. 478
Sterling introduces Bayer Select line of analgesics. Product Announcement 312
Store brands combat recession. 798
Survey eyes support staff. 306
Taro Vit posts substantial growth. 578
The unlimited market: over-50 consumers are a vibrant, affluent group. 949
Thrifty tells vendors of plans for renewal. 782
Walgreens enters Indianapolis arena. 709
Warner Chilcott emerges as a force in generics. 494
Whitmire passes milestone. 425
Who's 50+. 857
Wholesalers show resilience. Industry Overview 739

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |